Asuragen Molecular Diagnostics Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

A Multiplex PCR/CE CFTR Prototype Assay and Software Targets Mutations Including Poly-T/TG and Addresses >90% Allele Frequency in US Population
Brad Hall, Ph.D. - Presented at ACMG
Multisite Evaluation of a Single-tube SMN1/2 PCR/CE Assay System that Assesses Copy Number and Expanded Content for Spinal Muscular Atrophy
Huiping Zhu, Ph.D. - Presented at ACMG
Verification of a Single-tube PCR/CE Kit for SMN1/2 Copy Number and Variants Associated with Gene Duplication and SMA Disease Severity
Kevin Kelnar - Presented at ACMG
A Deep Learning Method for High-Throughput FMR1 Triplet Repeat Screening
Lando Ringel - Presented at AMP
A Multiplex PCR/CE CFTR Assay Resolves Zygosity of the 23 ACMG/ACOG-recommended CFTR Variants and Sizes poly-T and TG Repeats in a Single Tube
Pranesh Rao - Presented at AMP
A Rapid Diagnostic and Screening System for Spinal Muscular Atrophy that Reports Copy Number Changes, Single Nucleotide Variants and Small Indels
Huiping Zhu, Ph.D. - Presented at AMP
A Single-Platform Technology for Proteogenetic Biomarker Analysis in Oncology: Complementary Protein and RNA Quantification Relevant to Targeted and Immuno-therapies in Non-Small Cell Lung Cancer
Shobha Gokul - Presented at AMP
FMR1 methylation and sizing PCR assays improve sensitivity and efficiency in clinical testing for Fragile X syndrome, revealing some uncommon and unexpected results
Collaboration with Greenwood Genetic Center - Presented at ASHG
Clinical validation and implementation of a highly efficient and sensitive dual molecular diagnostic assay for myotonic dystrophy type 1
Collaboration with Children's Mercy Hospital - Presented at ASHG
A Deep Learning Framework for Interpreting Repetitive DNA Sequence in Heritable Disease
Jessica Larson, Ph.D. - Presented at ASHG
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top